Showing posts with label ABT-494 Phase 2 clinical trials in patients with rheumatoid arthritis. Show all posts
Showing posts with label ABT-494 Phase 2 clinical trials in patients with rheumatoid arthritis. Show all posts
Tuesday, October 20, 2015

AbbVie reports positive results from ABT-494 Phase 2 clinical trials in patients with rheumatoid arthritis

›
AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced results from two Phase 2 clinical trials evaluating its inves...